Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Jun 30;117(26):7185.
doi: 10.1182/blood-2011-04-349142.

Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis

H Joachim Deeg, Frederick R Appelbaum
Comment

Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis

H Joachim Deeg et al. Blood. .
No abstract available

PubMed Disclaimer

Comment on

  • How I treat myelofibrosis.
    Tefferi A. Tefferi A. Blood. 2011 Mar 31;117(13):3494-504. doi: 10.1182/blood-2010-11-315614. Epub 2011 Jan 3. Blood. 2011. PMID: 21200024 Review.

References

    1. Tefferi A. How I treat myelofibrosis. Blood. 2011;117(13):3494–3504. - PubMed
    1. Kerbauy DMB, Gooley TA, Sale GE, et al. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia. Biol Blood Marrow Transplant. 2007;13(3):355–365. - PubMed
    1. Rezvani AR, McCune JS, Batchelder A, Storer BE, McDonald GB, Deeg HJ. Low toxicity and mortality with reversed-order conditioning (cyclophosphamide followed by targeted intravenous busulfan) in allogeneic hematopoietic cell transplantation: preliminary results fo a prospective clinical trial [abstract]. Blood (ASH Annual Meeting Abstracts) 2009;114(22):482–483. Abstract 1175.
    1. Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011;29(4):392–397. - PubMed
    1. Scott BL, Gooley TA, Linenberger ML, et al. International working group scores predict post-transplant outcomes in patients with myelofibrosis [abstract]. Blood (ASH Annual Meeting Abstracts) 2010;116(21):1272. Abstract 3085.